Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-576-1 | CAS number: 3148-73-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
- ADME in humans: bioaccumulation is not expected in humans, Ellard 1976
- metabolism in humans: plasma-halflife between 5 and 40 h, Lauterburg 1985a
- metabilism in humans: rapid acetylators metabolise a much smaller dose fraction to 14CO2 than slow acetylators, Lauterburg 1985b
Additional information
A couple of studies are available that touch the toxicokinetics of diacetylhydrazine in humans, though none of them explicitly focus on this substance. On the contrary, the results are usually present as supplement to analysis on the toxicokinetics of isoniazid or acetylhydrazine.
Ellard 1976 analysed absorption, distribution, metabolism and excretion of isoniazid and its metabolites in different experimental settings in humans. The single exposure was via the oral route with water as vehicle. In this entry only the results for diacetylhydrazine are regarded. Based on the development of urine levels diacetylhydrazine is absorbed to a high extent (> 77 %) in both volunteers after a dose of ca. 1.85 mg/kg bw. No metabolites of diacetylhydrazine are detected. All hydrazines detected are identical to the parent diacetylhydrazine. The half-life is ca. 5 h both in the slow as well as in the rapid acetylator. Therefore, bioaccumulation is not to be expected in humans.
In Lauterburg 1985a the toxicokinetics of isoniazid and its metabolites was analysed in humans. Overnight fasted human volunteers that have given informed consent were applied with 300 mg of isoniazid per oral (dissolved in water). Blood was sampled once 2 h post dosing and another 8 times until 35 h post dosing. Urine sampling was conducted up to 48 h post treatment. The plasma-halflife of diacetylhydrazine was found to be between 5 and 40 h in this experiment. All other results presented correspond to the toxikokinetics of isoniazid or acetylhydrazine.
Lauterburg 1985b regarded the toxicokinetic of isoniazid and its metabolites in humans. Overnight fasted human volunteers that have given informed consent were applied with 300 mg of isoniazid per oral plus 13 mg C14-labelled acetylhydrazine (dissolved in water). Blood was sampled at intervals for 4 h post dosing in all participants and for 36 h in 6 volunteers. Expired CO2 was analysed for the concentration of C14 (analysis period not stated). Rapid acetylators metabolise a much smaller dose fraction to 14CO2 than slow acetylators. All other results presented correspond to the toxikokinetic of isoniazid or acetylhydrazine.
The study from Iguchi, 1977, was disregarded as in this abstract, it was only stated that a GC-MS method was successfully established to quantify isoniazid, acetyl isoniazid, acetylhydrazine and diacetylhydrazine in human urine.
In summary, it can be stated that diacetylhydrazine is a metabolite inter alia of isoniazid and hydrazines. Results from Ellard (1976) showed that 1,2-acetylhydrazine is rather stable and its hydrolysis to acetylhydrazine is rather slow. After systemic absorption, which takes place with a high efficiency via the oral route (no data for the dermal or inhalation route, Ellard 1976) the substance is excreted rather quickly (half-life of 5 h, Ellard 1976). Accordingly, bioaccumulation is not to be expected in humans.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.